The Government will invest $27 million to provide affordable access to three new medicines through the Pharmaceutical Benefits Scheme (PBS), helping Australians living with complications following stroke, fighting cancer, and experiencing syphilis in northern, central and southern Australia. The September 1 PBS listings will include amending the current listing for Opdivo® (Nivolumab) for the treatment…
The Government is investing $56 million to provide cheaper medicines for members of our community who have aggressive forms of cancer and inflammatory conditions, the Federal Member for Page Kevin Hogan said. “We are listing four drugs on the PBS to help patients living with these debilitating and often life threatening conditions,” he said. Under…
The Government is investing more than $200 million to list four new breakthrough cancer treatments on the Pharmaceutical Benefits Scheme (PBS), saving patients up to a quarter of a million dollars a year, Federal Member for Page Kevin Hogan said. Mr Hogan said patients with leukaemia, advanced kidney cancer, bladder cancer and liver cancer…
Two new drugs for the treatment of the skin condition psoriasis are now more affordable after the Government listed them on the PBS, Federal Member for Page Kevin Hogan said. “Patients currently pay around $30,200 a year for Tremfya and $32,600 a year for Ilumya,” he said. “Thanks to our investment, from next month the…
Members of our community who have lung cancer will save close to $90,000 each year after the Government listed Tagrisso on the PBS, the Federal Member for Page Kevin Hogan said. “Patients currently pay close to $8,000 per script or almost $88,000 per year for this treatment without subsidised access through the PBS. “Thanks to…